Literature DB >> 25893797

Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group.

Vadim Shevyrin1, Vladimir Melkozerov, Alexander Nevero, Oleg Eltsov, Yuri Shafran, Yuri Morzherin, Albert T Lebedev.   

Abstract

Illicit new psychoactive substances (NPS) are a serious threat to health throughout the world. Such NPS do not usually pass preliminary pharmacological trials. In 2014, we identified a series of five new synthetic cannabinoids with an indazole-3-carboxamide structure bearing an N-1-methoxycarbonylalkyl group. The compounds have very high cannabimimetic activity which has caused mass severe intoxication and deaths. The compounds were identified by means of gas chromatography-mass spectrometry (GC-MS), including high-resolution mass spectrometry (GC-HRMS), ultra-high-performance liquid chromatography-high-resolution tandem mass spectrometry (UHPLC-HRMS(2)), and (1)H and (13)C nuclear magnetic resonance spectroscopy (NMR). The peculiarities of mass-spectral fragmentation of the compounds after electron ionization (EI) ionization and collision-induced dissociation (CID) were studied. The analytical characteristics reported for the compounds will enable their identification in a variety of materials seized from criminals.Graphical Abstract.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893797     DOI: 10.1007/s00216-015-8612-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  7 in total

1.  Identification of MDMB-FUBINACA in commercially available e-liquid formulations sold for use in electronic cigarettes.

Authors:  Michelle R Peace; Rose I Krakowiak; Carl E Wolf; Alphonse Poklis; Justin L Poklis
Journal:  Forensic Sci Int       Date:  2016-12-27       Impact factor: 2.395

2.  Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.

Authors:  Matilda Bäckberg; Luiza Tworek; Olof Beck; Anders Helander
Journal:  J Med Toxicol       Date:  2016-09-16

3.  Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.

Authors:  Claude Guillou; Fabiano Reniero; Joana Lobo Vicente; Margaret Holland; Kamil Kolar; Hubert Chassaigne; Salvatore Tirendi; Herve Schepers
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

4.  Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE.

Authors:  Lukas Mogler; Sebastian Halter; Maurice Wilde; Florian Franz; Volker Auwärter
Journal:  Forensic Toxicol       Date:  2018-10-05       Impact factor: 4.096

Review 5.  Developments in high-resolution mass spectrometric analyses of new psychoactive substances.

Authors:  Joshua Klingberg; Bethany Keen; Adam Cawley; Daniel Pasin; Shanlin Fu
Journal:  Arch Toxicol       Date:  2022-02-09       Impact factor: 5.153

6.  Identification of the synthetic cannabinoid-type new psychoactive substance, CH-PIACA, in seized material.

Authors:  Daniel Pasin; Michael Nedahl; Christian Brinch Mollerup; Christian Tortzen; Lotte Ask Reitzel; Petur Weihe Dalsgaard
Journal:  Drug Test Anal       Date:  2022-06-16       Impact factor: 3.234

7.  The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities.

Authors:  Mitchell Longworth; Samuel D Banister; James B C Mack; Michelle Glass; Mark Connor; Michael Kassiou
Journal:  Forensic Toxicol       Date:  2016-04-27       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.